(Q34525086)

2 August 2017

1 reference

title

Pharmacology of neuropeptide Y receptor antagonists. Focus on cardiovascular functions (English)

1 reference

2 August 2017

1 reference

1 reference

Rickard E Malmström

1

1 reference

PubMed ID

12106798

2 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

European Journal of Pharmacology

2 August 2017

1 reference

2 August 2017

447

1 reference

2 August 2017

1

1 reference

2 August 2017

11-30

1 reference

Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y1- and Y2-receptor-mediated cardiovascular effects in the anesthetized guinea pig, rat, and rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y family of hormones: receptor subtypes and antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

BIBP3226 inhibits neuropeptide Y and pancreatic polypeptide potentiated neurogenic vasoconstriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Complete L-alanine scan of neuropeptide Y reveals ligands binding to Y1 and Y2 receptors with distinguished conformations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Morphological classifications of vertebrate blood capillaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Binding properties of three neuropeptide Y receptor subtypes from zebrafish: comparison with mammalian Y1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

The Y1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

The changing face of autonomic neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

The involvement of neuropeptide Y Y1 receptors in the blood pressure baroreflex: studies with BIBP 3226 and BIBO 3304

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Coronary artery infusion of neuropeptide Y in patients with angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Chromatographic characterisation of the circulating neuropeptide Y immunoreactivity from patients with phaeochromocytoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

High-affinity neuropeptide Y receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Increased density of perivascular nerves to the major cerebral vessels of the spontaneously hypertensive rat: differential changes in noradrenaline and neuropeptide Y during development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Role of neuropeptide Y in renal sympathetic vasoconstriction: studies in normal and congestive heart failure rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Different neuropeptsde Y receptor subtypes in rat and rabbit vas deferens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Suppression of neuropeptide Y1 receptor function in SK-N-MC cells by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Benextramine: a long-lasting neuropeptide Y receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

[(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y antagonistic properties of D-myo-inositol-1.2.6-trisphosphate in guinea pig basilar arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Release of neuropeptide Y and hemodynamic changes during surgical removal of human pheochromocytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

NPY receptor subtype in the rabbit isolated ileum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Characterization of a selective antagonist of neuropeptide Y at the Y2 receptor. Synthesis and pharmacological evaluation of a Y2 antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Postexercise ischemia is associated with increased neuropeptide Y in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Role of neuropeptide Y in cold stress-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y release from human heart is enhanced during prolonged exercise in hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Perivascular innervation of the mesenteric artery in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Adrenergic and neuropeptide Y supersensitivity in denervated nasal mucosa vasculature of the pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Sympathetic vascular control of the pig nasal mucosa (2): Reserpine-resistant, non-adrenergic nervous responses in relation to neuropeptide Y and ATP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neurogenically evoked cerebral artery constriction is mediated by neuropeptide Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Localization of APP, a postulated new hormone, to a pancreatic endocrine cell type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Peptide-containing nerves around blood vessels of stroke-prone spontaneously hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to α-adrenoceptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Pharmacological characterization of neuropeptide Y and noradrenaline mechanisms in sympathetic control of pig spleen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y and non-adrenergic sympathetic vascular control of the cat nasal mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y Y1 receptor mediated mesenteric vasoconstriction in the pig in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Endogenous NPY acting on the Y1 receptor accounts for the long-lasting part of the sympathetic contraction in guinea-pig vena cava: evidence using SR 120107A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Effects of the neuropeptide YY1 receptor antagonist SR 120107A on sympathetic vascular control in pigs in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

In vivo characterization of the novel neuropeptide Y Y1 receptor antagonist H 409/22

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Pharmacology of H 394/84, a dihydropyridine neuropeptide Y Y(1) receptor antagonist, in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Nitric oxide inhibition of renal vasoconstrictor responses to sympathetic cotransmitters in the pig in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y(2) receptor evidenced by BIIE0246.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Evidence for two neuropeptide Y receptors mediating vasoconstriction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Endothelial dysfunction: from physiology to therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Roles of neuropeptide Y and noradrenaline in sympathetic neurotransmission to the thoracic vena cava and aorta of guinea-pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Structural requirements for neuropeptide Y in mast cell and G protein activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Actions of neuropeptide Y on innervated and denervated rat tail arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Prolonged non-adrenergic inhibition of cardiac vagal action following sympathetic stimulation: neuromodulation by neuropeptide Y?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Characterization of NPY receptors mediating contraction in rat intramyocardial coronary arteries

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Neuropeptide Y Y1 receptors are involved in the vasoconstriction caused by human sympathetic nerve stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Release of neuropeptide Y upon haemorrhagic hypovolaemia in relation to vasoconstrictor effects in the pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

SR 120819A, an orally-active and selective neuropeptide Y Y1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Characterization of NPY receptors controlling lipolysis and leptin secretion in human adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

C-terminal neuropeptide Y fragments are mast cell-dependent vasodepressor agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Role of neuropeptide Y in the development of two-kidney, one-clip renovascular hypertension in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Elevated insulin, norepinephrine, and neuropeptide Y in hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y--a cotransmitter with noradrenaline and adenosine 5'-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y analog with selective antagonism of effects mediated by postjunctional Y1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Renal and cardiovascular role of the neuropeptide Y Y1 receptor in ischaemic heart failure rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901889-7

10.1016/S0014-2999(02)01889-7

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

12106798